In a prespecified secondary analysis of MASTER DAPT (4579 high bleeding risk patients; 976 with bifurcation PCI), abbreviated vs standard DAPT did not differ in net adverse or ischaemic events; bleeding HR was 0.83 (95% CI 0.53-1.30) with and 0.65 without bifurcation PCI.
Secondary analysisn = 4,579
Chevalier et al. Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT Trial